Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Article in English | WPRIM | ID: wpr-198650

ABSTRACT

OBJECTIVES: We established a Wistar rat model of asthma caused by toluene diisocyanate (TDI) exposure, and investigated the relationship between TDI exposure concentrations and respiratory hypersensitivity, airway inflammation, and cytokine secretions in animals, to better understand the mechanism of TDI induced occupational asthma. METHODS: Wistar rats were exposed to two different concentrations of TDI vapor four hours a day for five consecutive days. Bronchoalveolar lavage (BAL) was performed, and differential leucocytes from the BAL fluid were analyzed. Lung histopathological examination was carried out to investigate the inflammatory status in the airways. Production of cytokines interleukin (IL)-4 and IL-5 productions in the BAL fluid in vivo was determined with enzyme-linked immunosorbent assay kits. RESULTS: The TDI-exposed rats exhibited greater airway hypersensitivity symptoms than the control rats. The BAL differential cell count and lung histopathological examination demonstrated that inflammation reactions were present in both the central and peripheral airways, characterized with marked infiltration of eosinophils in the TDI-exposed rats. The cytokine assay showed that IL-4 and IL-5 were predominantly produced in the BAL fluid in vivo. CONCLUSIONS: These findings imply that TDI exposure concentrations may greatly affect the occurrence and extent of inflammatory events and that Th2 type cytokines may play an important role in the immunopathogenesis of TDI-induced occupational respiratory hypersensitivity.


Subject(s)
Animals , Female , Rats , Bronchoalveolar Lavage Fluid/chemistry , Enzyme-Linked Immunosorbent Assay , Eosinophils/cytology , Gases/chemistry , Hypersensitivity/pathology , Interleukin-4/analysis , Interleukin-5/analysis , Lung/drug effects , Rats, Wistar , Toluene 2,4-Diisocyanate/toxicity
2.
Article in English | WPRIM | ID: wpr-153075

ABSTRACT

The development of a serological marker for early diagnosis of isocyanate-induced occupational asthma (isocyanate-OA) may improve clinical outcome. Our previous proteomic study found that expression of vitamin D-binding protein (VDBP) was upregulated in the patients with isocyanate-OA. In the present study, we evaluated the clinical relevance of VDBP as a serological marker in screening for isocyanate-OA among exposed workers and its role in the pathogenesis of isocyanate-OA. Three study groups including 61 patients with isocyanate-OA (group I), 180 asymptomatic exposed controls (AECs, group II), 58 unexposed healthy controls (NCs, group III) were enrolled in this study. The baseline serum VDBP level was significantly higher in group I compared with groups II and III. The sensitivity and specificity for predicting the phenotype of isocyanate-OA with VDBP were 69% and 81%, respectively. The group I subjects with high VDBP (> or = 311 microg/ml) had significantly lower PC20 methacholine levels than did subjects with low VDBP. The in vitro studies showed that TDI suppressed the uptake of VDBP into RLE-6TN cells, which was mediated by the downregulation of megalin, an endocytic receptor of the 25-hydroxycholecalciferol-VDBP complex. Furthermore, toluene diisocyanate (TDI) increased VEGF production and secretion from this epithelial cells by suppression of 1,25-dihydroxycholecalciferol [1,25(OH)2D3] production. The findings of this study suggest that the serum VDBP level may be used as a serological marker for the detection of isocyanate-OA among workers exposed to isocyanate. The TDI-induced VEGF production/secretion was reversed by 1,25(OH)2D3 treatment, which may provide a potential therapeutic strategy for patients with isocyanate-OA.


Subject(s)
Adult , Animals , Female , Humans , Male , Middle Aged , Rats , Asthma/blood , Cell Line , Epithelial Cells , Gene Expression/drug effects , Isocyanates/toxicity , Occupational Diseases/blood , Toluene 2,4-Diisocyanate/toxicity , Vitamin D-Binding Protein/blood
3.
Yonsei Medical Journal ; : 773-781, 2006.
Article in English | WPRIM | ID: wpr-169438

ABSTRACT

To evaluate the clinical significance of autoantibodies to three major epithelial cytokeratins (CK) -- CK8, CK18, and CK19 -- we compared 66 patients with toluene diisocyanate (TDI)-induced asthma (group I) with three control groups: 169 asymptomatic exposed subjects (group II), 64 patients with allergic asthma (group III), and 123 unexposed healthy subjects (group IV). Serum IgG, specific for human recombinant CKs, were measured by ELISA (enzyme linked immunosorbent assay), and ELISA inhibition tests were performed. The existence of these antibodies was confirmed by IgG immunoblot analysis. Anti-TDI-HSA (human serum albumin) IgE and IgG antibodies were measured by ELISA in the same set of the patients. The prevalence of CK8, CK18, and CK19 auotantibodies in group I was significantly higher than in the other three groups. Results of the ELISA inhibition test showed significant inhibition with the addition of three CKs in a dose-dependent manner. No significant association was found between CK autoantibodies and the prevalence of anti- TDI-HSA IgG and IgE antibodies. These results suggest that autoantibodies to CK18 and CK19 can be used as serologic markers for identifying patients with TDI-induced asthma among exposed workers.


Subject(s)
Middle Aged , Male , Humans , Female , Adult , Toluene 2,4-Diisocyanate/toxicity , Sensitivity and Specificity , Occupational Diseases/chemically induced , Keratins/immunology , Keratin-8/immunology , Keratin-19/immunology , Keratin-18/immunology , Immunoblotting , Enzyme-Linked Immunosorbent Assay , Biomarkers/blood , Autoantibodies/blood , Asthma/chemically induced
4.
Article in English | WPRIM | ID: wpr-187040

ABSTRACT

This investigation was designed to confirm IL-8 production from human bronchial epithelial cells with toluene diisocyanate (TDI) exposure and to examine the effects of pro-inflammatory cytokine and dexamethasone. We cultured Beas-2B, a bronchial epithelial cell line with TDI-HSA conjugate and compared with those without conjugate. IL-8 in the supernatant was measured by ELISA. To evaluate the effect of proinflammatory cytokines, peripheral blood mononuclear cells (PBMC) were collected from TDI- and non-TDI asthma patients, and were added to the epithelial cell culture. Dexamethasone or antibodies to TNF-alpha and IL-1beta were pre-incubated with PBMC supernatant. There was a significant production of IL-8 from bronchial epithelial cells with addition of TDI-HSA conjugate in a dose-dependent manner, which was significantly augmented with addition of PBMC supernatant. Higher production of IL-8 was noted with addition of PBMC supernatant from TDI-asthma patients than in those from non-TDI asthma patients. IL-1beta and IL-1beta/TFNalpha antibodies were able to suppress the IL-8 productions. Pre-treatment of dexamethasone induced dose-dependent inhibition of the IL-8 production. These results suggest that the IL-8 production from bronchial epithelial cells contribute to neutrophil recruitment occurring in TDIinduced airway inflammation. IL-1beta released from PBMC of TDI-induced asthma patients may be one of the pro-inflammatory cytokines to enhance IL-8 production.


Subject(s)
Humans , Asthma/immunology , Bronchi/cytology , Cell Line , Dexamethasone/pharmacology , Epithelial Cells/cytology , Glucocorticoids/pharmacology , Interleukin-8/metabolism , Leukocytes, Mononuclear/cytology , Toluene 2,4-Diisocyanate/toxicity
5.
J. pneumol ; 15(2): 69-73, jun. 1989. ilus, tab
Article in Portuguese | LILACS | ID: lil-72676

ABSTRACT

Para previnir é importante identificar a reaçäo asmática que ocorre nos indivíduos sensibilizados aos isocianatos. En 48 indivíduos sensibilizados ao TDI, estudou-se a reaçäo pulmonar após exposiçäo provocada. Foram agrupados conforme suas reaçöes asmáticas: imediata, dual, tardia ou sem reaçäo. O volume expiratório forçado no 1§ segundo (VEF1) foi medido antes e depois da exposiçäo na concentraçäo de 10 a 15 ppb de TDI, seguindo-se a cada hora até a oitava. A dose provocativa (mg) de metacolina que causou a queda de 20% do VEF1 (DP2OVEF1) foi medida antes e depois da inalaçäo de TDI. O resultado do presente estudo sugere que o efeito broncoconstritor ao TDI ocorre nos indivíduos sensibilizados de forma variada, dependendo da reatividade brônquica de cada um, excluindo os efeitos irritativos inespecíficos das vias aéreas quando em exposiçäo a altas concentraçöes. O aumento da reatividade das vias aéreas a metacolina está associada aqueles indivíduos sensibilizados que desenvolvem a reaçäo asmática tardia/e ou dual e näo aos que desenvolvem a imediata ou näo reagem. Isso provavelmente se deva ao processo inflamatório que ocorre nos primeiros, sendo eles passíveis de tratamento preventivo


Subject(s)
Adult , Humans , Male , Female , Asthma/epidemiology , Bronchial Provocation Tests , Occupational Diseases , Toluene 2,4-Diisocyanate/toxicity , Asthma/prevention & control , Hypersensitivity, Delayed , Hypersensitivity, Immediate
SELECTION OF CITATIONS
SEARCH DETAIL